Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1973 2
1974 1
1975 3
1978 1
1980 2
1982 1
1984 1
1986 1
1988 2
1989 1
1990 2
1993 5
1994 3
1996 1
1997 1
1998 1
1999 4
2000 2
2001 1
2002 1
2003 1
2004 1
2005 1
2008 2
2009 1
2010 2
2011 1
2012 2
2013 1
2014 3
2015 1
2017 1
2019 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
How I treat warm autoimmune hemolytic anemia.
Barcellini W, Fattizzo B. Barcellini W, et al. Blood. 2021 Mar 11;137(10):1283-1294. doi: 10.1182/blood.2019003808. Blood. 2021. PMID: 33512406 Free article. Review.
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG) autoantibodies, with or without complement activation. ...The different pathogenic mechanisms, their complex interplay, and changes over time may …
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG) autoa …
Drug-induced hemolytic anemia: Pharmacological aspects.
Renard D, Rosselet A. Renard D, et al. Transfus Clin Biol. 2017 Sep;24(3):110-114. doi: 10.1016/j.tracli.2017.05.013. Epub 2017 Jun 23. Transfus Clin Biol. 2017. PMID: 28648734 Review.
Drug-induced hemolytic anemia is a very rare but potentially lethal adverse drug reaction, which can take the form of oxidative damage to vulnerable erythrocytes (as in glucose-6-phosphate dehydrogenase deficiency), drug-induced thromboti …
Drug-induced hemolytic anemia is a very rare but potentially lethal adverse drug reaction, which can take the fo …
Drug-induced immune hemolytic anemia.
Garratty G. Garratty G. Hematology Am Soc Hematol Educ Program. 2009:73-9. doi: 10.1182/asheducation-2009.1.73. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008184 Review.
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide the optimal serological tests to confirm the diagnosis. ...In these latter cases, the drug affects the immune system, causing production of …
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide …
Autoimmune hemolytic anemia.
Gehrs BC, Friedberg RC. Gehrs BC, et al. Am J Hematol. 2002 Apr;69(4):258-71. doi: 10.1002/ajh.10062. Am J Hematol. 2002. PMID: 11921020 Free article. Review.
Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. However, autoimmune hemolytic anemia (AIHA) must be considered in the differential diagnosis of hemolytic anemias, especially if the patient has a concomitant lymphop …
Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. However, autoimmune hemolytic anemia …
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
Loriamini M, Cserti-Gazdewich C, Branch DR. Loriamini M, et al. Int J Mol Sci. 2024 Apr 12;25(8):4296. doi: 10.3390/ijms25084296. Int J Mol Sci. 2024. PMID: 38673882 Free PMC article. Review.
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells (RBCs). ...Although usually self-remitting, management may consider monoclonal antibodies to C1q or C5. (5) Direct antiglobulin test-negative …
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells ( …
The direct antiglobulin test: a critical step in the evaluation of hemolysis.
Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. Zantek ND, et al. Am J Hematol. 2012 Jul;87(7):707-9. doi: 10.1002/ajh.23218. Epub 2012 May 6. Am J Hematol. 2012. PMID: 22566278 Free article. Review.
This review highlights the most common clinical situations where the DAT can help classify causes of hemolysis, including autoimmune hemolytic anemia, transfusion-related hemolysis, hemolytic disease of the fetus/newborn, drug-induced …
This review highlights the most common clinical situations where the DAT can help classify causes of hemolysis, including autoimmune …
Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.
Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Newman K, et al. Autoimmun Rev. 2013 May;12(7):784-91. doi: 10.1016/j.autrev.2013.02.001. Epub 2013 Feb 24. Autoimmun Rev. 2013. PMID: 23462431 Review.
Anemia could be due to chronic disease, secondary to renal insufficiency, blood loss, drug induced or autoimmune hemolysis. There are other very rare causes of anemia secondary to SLE which include red cell aplasia, aplastic anemia, and m …
Anemia could be due to chronic disease, secondary to renal insufficiency, blood loss, drug induced or autoimmune …
Drug-induced hemolytic anemia.
Beutler E. Beutler E. Pharmacol Rev. 1969 Mar;21(1):73-103. Pharmacol Rev. 1969. PMID: 4887725 Review. No abstract available.
Drug-induced autoimmune hemolytic anemia.
Petz LD. Petz LD. Transfus Med Rev. 1993 Oct;7(4):242-54. doi: 10.1016/s0887-7963(93)70144-3. Transfus Med Rev. 1993. PMID: 8241613 Review. No abstract available.
Management of Select Thrombocytopenias.
VanDruff TA. VanDruff TA. AACN Adv Crit Care. 2019 Summer;30(2):165-180. doi: 10.4037/aacnacc2019186. AACN Adv Crit Care. 2019. PMID: 31151947 Review.
Evaluating, diagnosing, and managing patients with consumptive thrombocytopenia is challenging because of the overlapping nature of many of the diseases that reduce platelet counts. Immune thrombocytopenia (and its variations), drug-induced immune thrombocytopenia, …
Evaluating, diagnosing, and managing patients with consumptive thrombocytopenia is challenging because of the overlapping nature of many of …
59 results